Medical Students Articles

Med Student

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Singh JA et al. – Based upon indirect comparisons, anakinra seemed less efficacious than etanercept, adalimumab and rituximab and etanercept seemed to cause fewer withdrawals due to adverse events than adalimumab, anakinra and infliximab. Significant heterogeneity in characteristics of trial populations imply that these finding must be interpreted with caution. These findings can inform physicians and patients regarding their choice of biologic for treatment of RA.

Today in Rheumatology...keeping you current

Chronic widespread pain and fibromyalgia: Two sides of the same coin?
Current Rheumatology Reports, 12/04/09

Role and place of methotrexate in vasculitis management
International Journal of Clinical Rheumatology, 12/04/09

Denuded subchondral bone and knee pain in persons with knee osteoarthritis
Arthritis & Rheumatism, 12/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address